Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healios KK Ord Shs HLOSF

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.


PINL:HLOSF - Post by User

Comment by sweenbyon Aug 26, 2010 12:36pm
396 Views
Post# 17386249

RE: Failed to pass 10 :1 SC

RE: Failed to pass 10 :1 SC
Halo Resources Ltd
Symbol C : HLO
Shares Issued 170,143,464
Close 2010-08-25 C$ 0.03
Recent Sedar Documents
View Original Document

Halo Resources names directors, to arrange rollback

2010-08-26 12:04 ET - News Release

Mr. Marc Cernovitch reports

HALO AGM RESULTS

Halo Resources Ltd.'s shareholders, at its annual and special meeting held Aug. 20, 2010, elected Lynda Bloom, Marc Cernovitch, Nick DeMare, Tom Healy, William Lee, Derek Cathcart, Julie Lassonde and Gary Ostry as directors of the company. All items put forth at the meeting were approved by the shareholders, including an ordinary resolution to ratify the company's stock option plan, pursuant to which Halo may grant stock options on up to 10 per cent of the issued and outstanding common shares at the time of the grant, as well as a special resolution approving a share consolidation on the basis of one new common share for 10 old common shares.

At a meeting of directors held subsequent to the meeting, Ms. Bloom was appointed president and chief executive officer, Mr. Cernovitch as chairman, Mr. DeMare as chief financial officer, Mr. healy as senior vice-president and chief operating officer, and Harvey Lim as corporate secretary of the company. The directors also approved, subject to the acceptance of the TSX Venture Exchange, the implementation of the one-new-share-for-10-old consolidation, with no fractional shares to be issued. Any fraction of a share will be rounded down to the nearest whole number. Halo currently has 170,143,464 common shares issued and outstanding. After the consolidation, there will be approximately 17,014,346 common shares issued and outstanding.

<< Previous
Bullboard Posts
Next >>